Reply to 'More study still needed on the use of bromocriptine in the treatment of peripartum cardiomyopathy'

Affiliations

¹ Department of Cardiology and Angiology, Medical School Hannover, Germany.
² Hatter Institute for Cardiovascular Research in Africa, University of Cape Town, Cape Town, South Africa.

Comment

Denise Hilfiker-Kleiner et al. Eur Heart J. 2018.

. 2018 Nov 14;39(43):3905.

doi: 10.1093/eurheartj/ehy603.

¹ Department of Cardiology and Angiology, Medical School Hannover, Germany.
² Hatter Institute for Cardiovascular Research in Africa, University of Cape Town, Cape Town, South Africa.

No abstract available

Comment on

Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study.
Hilfiker-Kleiner D, Haghikia A, Berliner D, Vogel-Claussen J, Schwab J, Franke A, Schwarzkopf M, Ehlermann P, Pfister R, Michels G, Westenfeld R, Stangl V, Kindermann I, Kühl U, Angermann CE, Schlitt A, Fischer D, Podewski E, Böhm M, Sliwa K, Bauersachs J. Hilfiker-Kleiner D, et al. Eur Heart J. 2017 Sep 14;38(35):2671-2679. doi: 10.1093/eurheartj/ehx355. Eur Heart J. 2017. PMID: 28934837 Free PMC article. Clinical Trial.
More study still needed on the use of bromocriptine in the treatment of peripartum cardiomyopathy.
Fett JD. Fett JD. Eur Heart J. 2018 Nov 14;39(43):3904. doi: 10.1093/eurheartj/ehy598. Eur Heart J. 2018. PMID: 30272149 No abstract available.